MedTrace Logo

Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?

NCT04445610 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-06-26

No results posted yet for this study

Summary

The following two mechanisms that explain the ability of measles vaccine to cause partial protection against COVID-19. The first is that measles vaccine may increase the ability of the immune system to fight off pathogens other than measles due to the generated bystander immunity that would enhance the overall immunity against the new coronavirus. The second is that SARS-CoV-2 is proven to have structure similarities with measles, which may cause cross-reactivity and immunity between measles vaccines and COVID-19, leading to partial protection against COVID-19 in vaccinated subjects

Conditions

  • Coronavirus (COVID-19)

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Amira Al Balakosy, M.D · Ain Shams University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-09-01
Completion
2020-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445610 on ClinicalTrials.gov